BRIEF published on 12/02/2024 at 09:05, 1 year 5 months ago Eckert & Ziegler lance la production d'actinium 225 pour faire face à la pénurie mondiale Produits Radiopharmaceutiques Médecine Nucléaire Production D'actinium 225 Approvisionnement En Isotopes Certification GMP
PRESS RELEASE published on 12/02/2024 at 09:00, 1 year 5 months ago Eckert & Ziegler Begins Production of Actinium-225, Paving the Way for GMP-Grade Supply Eckert & Ziegler starts Actinium-225 production in collaboration with Czech Academy of Sciences, aiming for GMP-grade supply to boost alpha-emitting radiopharmaceuticals development Eckert & Ziegler Production Radiopharmaceuticals Actinium-225 GMP-grade
BRIEF published on 11/27/2024 at 09:05, 1 year 5 months ago Eckert & Ziegler Gains European Approval for Theralugand® Cancer Therapy Radiopharmaceuticals Lutetium-177 European Approval Theralugand®
BRIEF published on 11/27/2024 at 09:05, 1 year 5 months ago Eckert & Ziegler obtient l'approbation européenne pour Theralugand® Produits Radiopharmaceutiques Thérapie Contre Le Cancer Lutetium-177 Theralugand® Agrément Européen
PRESS RELEASE published on 11/27/2024 at 09:00, 1 year 5 months ago Eckert & Ziegler Achieves European Approval for Theralugand® - Lutetium-177 Chloride (n.c.a) Eckert & Ziegler receives EC approval for Theralugand® - Lutetium-177 Chloride, expanding cancer therapy options in Europe Eckert & Ziegler Cancer Therapy EC Approval Theralugand Lutetium-177 Chloride
BRIEF published on 11/22/2024 at 15:32, 1 year 5 months ago Eckert & Ziegler Increases 2024 Financial Forecast Eckert & Ziegler Sales Increase Financial Forecast EBIT Growth 2024 Business
BRIEF published on 11/22/2024 at 15:32, 1 year 5 months ago Eckert & Ziegler augmente ses prévisions financières pour 2024 Eckert & Ziegler Prévisions Financières Augmentation Des Ventes Croissance Du Résultat D'exploitation (EBIT) Entreprise 2024
PRESS RELEASE published on 11/22/2024 at 15:27, 1 year 5 months ago EQS-Adhoc: Eckert & Ziegler raises its forecast for the current financial year once again Eckert & Ziegler SE raises its forecast for the current financial year with sales of EUR 290 million and EBIT of EUR 60 million. Investor contact: Karolin Riehle, EZAG Financial Year Forecast Eckert & Ziegler SE EUR 290 Million EBIT EUR 60 Million
BRIEF published on 11/14/2024 at 07:50, 1 year 5 months ago Eckert & Ziegler Reports Strong Growth in First Nine Months of 2024 Eckert & Ziegler 2024 Forecast Financial Growth Medical Segment Isotope Products
BRIEF published on 11/14/2024 at 07:50, 1 year 5 months ago Eckert & Ziegler annonce une forte croissance au cours des neuf premiers mois de 2024 Croissance Financière Eckert & Ziegler Prévisions Pour 2024 Secteur Médical Produits Isotopiques
Published on 05/08/2026 at 01:50, 42 minutes ago Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 1 hour 47 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 2 hours 32 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 3 hours 2 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 3 hours 17 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 23:23, 3 hours 8 minutes ago H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 3 hours 17 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 4 hours 26 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 5 hours 49 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 7 hours 46 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 19:15, 7 hours 17 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 7 hours 17 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 7 hours 26 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 7 hours 26 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 7 hours 32 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
